HomeNewsTrendsHealthAnalysis: India has long been short of hospital beds. The pandemic intensified the shortage

Analysis: India has long been short of hospital beds. The pandemic intensified the shortage

When India country was ravaged by an aggressive second wave of the virus in March-April, there were fewer beds for Covid patients, not just in Delhi but also in many other parts of the country, including Mumbai.

April 30, 2021 / 12:16 IST
Story continues below Advertisement
Prayagraj: Security guard put a poster of Bed full outside a Private Covid Hospital, as coronavirus cases spike in Prayagraj on Thursday, April 22, 2021.
Editorial credit: prabhat kumar verma / Shutterstock.com
Prayagraj: Security guard put a poster of Bed full outside a Private Covid Hospital, as coronavirus cases spike in Prayagraj on Thursday, April 22, 2021. Editorial credit: prabhat kumar verma / Shutterstock.com

As the first wave of the Covid-19 pandemic was ebbing late last year, India had a little more than 1.5 million isolation beds across 15,375 dedicated treatment facilities for a population of 1.38 billion. That translates to a skosh over 1 bed per 1,000 people. Just 18% of these were oxygen supported beds, according to the 2020-21 annual report of the ministry of health and family welfare.

Each of these dedicated facilities had about 5.2 intensive care unit (ICU) beds on average. In all, there were a total of 80,583 ICU beds for Covid patients, and about half of these were ventilator beds. These numbers were no doubt small yet seemed adequate as the transmission of the virus was relatively slow.

Story continues below Advertisement

Shortage Exposed By Pandemic

As the number of cases continued to decline in January 2021 and the number of patients requiring hospitalisation fell, many of these dedicated Covid facilities were discontinued or closed down. Among the ones discontinued were the 10,000-bed facility at the campus of Radha Saomi Satsang Beas in Chhattarpur, near the Delhi-Haryana border and the 1,000-bed facility run by the Defence Research and Development Organisation in Delhi Cantonment. Both ceased operations in February.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show